ArticleEuropean journal of human genetics : EJHG2026
NSMCE2 / MMS21 structural variant causes chromosome breakage syndrome with primordial dwarfism and severe lung disease.
Article in European journal of human genetics : EJHG, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
Primordial dwarfism (PD) is a genetic disorder characterized by severe intrauterine and postnatal growth failure. While some subtypes involve impaired DNA damage responses, the molecular basis of PD remains incompletely defined. We describe two siblings of non-consanguineous Indian-Jewish ancestry with a likely autosomal recessive syndrome featuring borderline intrauterine growth restriction, severe postnatal growth restriction, hypotonia, consistent dysmorphic features (elongated face, low-set ears, hypotelorism, prominent nose), hypothyroidism, late-onset insulin-dependent diabetes, borderline immune dysregulation, and recurrent pneumonia with interstitial lung disease, leading to death in adolescence. Karyotype and microarrays were normal, but cytogenetic analysis of PHA-stimulated lymphocytes revealed spontaneous chromosomal breakage and polyploidy, without hypersensitivity to cross-linking agents. Linkage analysis, whole genome sequencing, and Manta structural variant calling identified a homozygous tandem duplication within NSMCE2, NC_000008.11(NM_173685.4:c.265-11431_418+8879dup), validated by PCR and Sanger sequencing. RT-PCR of lymphoblastoid cells confirmed an aberrant transcript, predicted to cause a frameshift, premature stop codon, and loss of the SUMO domain. NSMCE2 encodes a core component of the SMC5/6 complex, essential for chromosome structure and repair. Only one prior report has linked NSMCE2 mutations to PD. Our findings determine the clinical and molecular spectrum of this severe chromosome breakage syndrome with PD, lung fibrosis, immune-endocrine abnormalities, and early lethality.
Identifiers
42768093What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.